The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.
Edwards raises 2026 forecast as TAVR sales surge Read More »
While the FDA did not announce the recipient names of the Commissioner’s National Priority Vouchers, the agency’s descriptions of the awarded products match those in development at Compass Pathways, Transcend Therapeutics and Usona Institute.
FDA awards priority vouchers to 3 undisclosed companies for investigational psychedelics Read More »
En un logro que durante mucho tiempo ha sido tema exclusivo de la ciencia-ficción, y que fascinará a un sector de la sociedad e inquietará a otro, unos científicos han agregado células cerebrales vivientes a una estructura artificial para usarlas como si fuesen la …
The private equity-backed anesthesia provider bought and bullied its way to market dominance in Texas, driving up prices for patients, the FTC alleged. The parties have now reached a deal, though USAP will not admit liability.
FTC, US Anesthesia Partners reach settlement in Texas price collusion case Read More »
Recientemente, el cometa C/2026 A1 (MAPS) sobrevoló el Sol a una distancia tremendamente corta de su superficie, unos 859 000 kilómetros, poco más del doble de la distancia que separa a la Luna de la Tierra. Se generó una gran expectación entre los observa …
Un cometa es destruido al pasar demasiado cerca del Sol Read More »
Unos científicos han observado por vez primera un exótico fenómeno que puede describirse como un entrelazamiento cuántico entre partículas reales y otras que solo son virtuales aunque su influencia es del todo real. El estudio es obra de un extenso equipo …
El uso de sistemas robóticos en la mesa de operaciones y para otras aplicaciones en hospitales y centros de salud sigue creciendo. En la fotografía vemos a Surgie, un robot humanoide diseñado para labores médicas de apoyo, a punto de aplicar ultrasonido a un paciente. Qui …
Neal and Azbee awards have validated our approach to reporting on the industry at a time of unprecedented shifts at the FDA and other federal agencies.
BioSpace elevates journalism as biopharma evolves in the Trump era Read More »
The report compiled by Sen. Maria Cantwell, D-Wash., found procedures in the state that were previously approved within around two weeks now take four to eight weeks to be authorized.
Medicare AI prior authorization pilot delaying care in Washington: report Read More »
Pfizer’s decision to cut its early-stage cancer asset was due to “strategic business reasons” and not driven by safety or efficacy concerns.
Pfizer culls early PD-L1 program after series of clinical wins, deals in cancer Read More »
